Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: A Phase 2a, Multicenter Prospective Trial.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: October 24, 2024
Efficacy and Safety of Inhaled Human Insulin (Exu hera®) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel Trial.
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: February 18, 2021
Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials.
Journal: CNS spectrums
Published: November 14, 2018
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: December 01, 2017
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: November 30, 2017
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
Journal: European heart journal
Published: July 27, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026